SS-31
$140.00
SS-31 10/50mg Peptide for sale USA warehouse
weight: 10/50mg/vial,10vials/box
Description
SS-31 peptide/vial hot sale online USA, buy to quality online.
SS-31, also known as Bendavia, is a novel mitochondria-targeting peptide that has shown potential therapeutic effects in various conditions related to mitochondrial dysfunction. Here’s a brief description :
-
Mechanism of Action:
- SS-31 is a small peptide that specifically targets mitochondria, the energy-producing organelles within cells. It has been designed to interact with cardiolipin, a phospholipid found in the inner mitochondrial membrane, where it helps stabilize the structure and function of mitochondria.
- Mitochondrial Protection:
- SS-31 works by binding to cardiolipin, which can become peroxidized and disrupted during oxidative stress. By stabilizing cardiolipin, helps preserve mitochondrial integrity, maintain electron transport chain function, and reduce mitochondrial reactive oxygen species (ROS) production.
- Therapeutic Potential:
- SS-31 has shown promise in various preclinical and clinical studies for conditions associated with mitochondrial dysfunction and oxidative stress. These conditions may include heart failure, ischemia-reperfusion injury, neurodegenerative diseases, and age-related decline in mitochondrial function.
-
Clinical Studies:
- Clinical trials have demonstrated that SS-31 can improve mitochondrial function, reduce oxidative damage, and potentially enhance tissue protection and recovery in ischemic heart disease and other conditions.
- Safety Profile:
- has generally been well-tolerated in clinical trials, with reported side effects being mild and transient. However, further research is needed to fully establish its long-term safety profile.
Overall, SS-31 represents a novel approach to targeting mitochondrial dysfunction and oxidative stress, potentially offering therapeutic benefits in various diseases where these mechanisms play a significant role.
effect
SS-31, also known as Bendavia, exerts its effects primarily by targeting mitochondria, the energy-producing powerhouses within cells. Here are the key effects :
-
Mitochondrial Protection:
- SS-31 interacts with cardiolipin, a crucial phospholipid in the inner mitochondrial membrane. During conditions of stress or injury, such as ischemia-reperfusion injury, cardiolipin can become oxidized and destabilized, leading to mitochondrial dysfunction. stabilizes cardiolipin, thereby protecting mitochondrial structure and function.
- Reduction of Oxidative Stress:
- Mitochondria are a primary source of reactive oxygen species (ROS) within cells. By stabilizing cardiolipin and preserving mitochondrial function, SS-31 helps reduce ROS production. This reduction in oxidative stress is beneficial in mitigating cellular damage and improving overall cell health.
-
Enhancement of ATP Production:
- ATP (adenosine triphosphate) is the primary energy currency of cells, produced through mitochondrial respiration. SS-31 has been shown to improve mitochondrial respiration efficiency, leading to increased ATP production. This enhanced energy supply is crucial for cellular functions and tissue viability, particularly in conditions where mitochondrial function is compromised.
- Tissue Protection and Repair:
- SS-31 has demonstrated protective effects in various preclinical and clinical studies involving conditions such as myocardial infarction (heart attack), stroke, and neurodegenerative diseases. By preserving mitochondrial function and reducing oxidative stress, helps promote tissue viability, enhance recovery from injury, and potentially reduce the extent of tissue damage.
- Anti-inflammatory Properties:
- In addition to its direct effects on mitochondria and oxidative stress, SS-31 may have anti-inflammatory properties. By improving mitochondrial function and reducing cellular stress, can contribute to a dampened inflammatory response, which is beneficial in various disease states characterized by inflammation.
Overall, SS-31 represents a promising therapeutic approach for conditions associated with mitochondrial dysfunction and oxidative stress. Its ability to protect mitochondria, reduce oxidative damage, enhance ATP production, and potentially modulate inflammation underscores its therapeutic potential in a range of diseases where these mechanisms play a significant role.
side effect
SS-31, or Bendavia, has generally shown a favorable safety profile in clinical trials and preclinical studies. However, like any medication or therapeutic agent, it’s important to consider potential side effects, although these tend to be minimal based on available data. Here are some aspects related to SS-31’s safety profile:
-
Mild and Transient Effects:
- Reported side effects of have generally been mild and transient. These may include mild irritation at the injection site or minor gastrointestinal discomfort, but such occurrences have been infrequent.
- Safety in Clinical Trials:
- Clinical trials evaluating SS-31 have not typically reported significant adverse events directly attributable to the peptide. Participants in these studies have generally tolerated well across various dosages and treatment durations.
- Long-term Safety:
- While short-term safety data appear promising, long-term studies are still limited. Further research is needed to fully understand SS-31’s safety profile over extended periods of use and in diverse patient populations.
Welcome to Inquiry:
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 20 × 20 × 20 cm |
| weight | 10mg/vial |
Reviews
There are no reviews yet.